Get informed when a big investor buys or sells
+ FollowLoading insider trades…
Loading congress trades…
| Market cap | $1.00 Million |
|---|---|
| Enterprise Value | $9.73 Million |
| Earnings per Share | $0 |
| Beta | -0.54 |
| Outstanding Shares | 5,000,000,000 |
| P/E Ratio | -19.67 |
|---|---|
| PEG | 19.55 |
| Price to Sales | - |
| Price to Book Ratio | -0.0 |
| Enterprise Value to Revenue | 162.24 |
| Enterprise Value to EBIT | -3.33 |
| Enterprise Value to Net Income | -3 |
| Total Debt to Enterprise | 0.9 |
| Debt to Equity | -0.74 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
Manzo Pharmaceuticals, Inc. is a specialized drug company that focuses on the discovery, creation, and evaluation of both proprietary and generic medical treatments and therapies. The company is actively developing Lacto-Freedom, a paten...